4//SEC Filing
Dhaliwal Jatinder 4
Accession 0001213900-24-060119
CIK 0001708331other
Filed
Jul 8, 8:00 PM ET
Accepted
Jul 9, 4:02 PM ET
Size
5.4 KB
Accession
0001213900-24-060119
Insider Transaction Report
Form 4
Dhaliwal Jatinder
Director
Transactions
- Award
Stock Option (right to buy)
2024-07-05+2,500→ 2,500 totalExercise: $0.58Exp: 2034-07-04→ Common Stock (2,500 underlying)
Footnotes (1)
- [F1]The option vests in full on the twelve-month anniversary of the grant date.
Documents
Issuer
Virpax Pharmaceuticals, Inc.
CIK 0001708331
Entity typeother
Related Parties
1- filerCIK 0002018476
Filing Metadata
- Form type
- 4
- Filed
- Jul 8, 8:00 PM ET
- Accepted
- Jul 9, 4:02 PM ET
- Size
- 5.4 KB